Roberto Chiarle
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 14
- CAR-T cell therapy research 11
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 43
- Immunology top 1%
- Immune Cell Function and Interaction 19
- Immunotherapy and Immune Responses 11
- Cancer Research top 1%
- Molecular Biology top 1%
- Ubiquitin and proteasome pathways 11
-
- Chronic Lymphocytic Leukemia Research 17
-
- Lung Cancer Treatments and Mutations 15
Roberto Chiarle
146 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 2.9k
- Pathology and Forensic Medicine 1.8k
- Immunology 1.5k
- Cancer Research 1.1k
- Molecular Biology 4.5k
Countries citing papers authored by Roberto Chiarle
This map shows the geographic impact of Roberto Chiarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Chiarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Chiarle more than expected).
Fields of papers citing papers by Roberto Chiarle
This network shows the impact of papers produced by Roberto Chiarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Chiarle. The network helps show where Roberto Chiarle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Chiarle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 41 | |
| 7 | 2023 | 62 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 27 | |
| 11 | 2021 | 39 | |
| 12 | 2018 | 12 | |
| 13 | 2017 | 20 | |
| 14 | 2016 | 31 | |
| 15 | 2016 | 20 | |
| 16 | 2014 | 18 | |
| 17 | 2010 | 12 | |
| 18 | 2009 | 71 | |
| 19 | 2008 | 41 | |
| 20 | 2007 | 70 |
About Roberto Chiarle
Roberto Chiarle is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Molecular Biology, having authored 149 papers that have together received 7.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (43 papers), Immune Cell Function and Interaction (19 papers), Chronic Lymphocytic Leukemia Research (17 papers), Lung Cancer Treatments and Mutations (15 papers), Cytokine Signaling Pathways and Interactions (14 papers), Ubiquitin and proteasome pathways (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (11 papers). The work is most often cited by research in Oncology (2.9k citations), Pathology and Forensic Medicine (1.8k citations), Immunology (1.5k citations), Cancer Research (1.1k citations) and Molecular Biology (4.5k citations). Roberto Chiarle has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Giorgio Inghirami, Chiara Ambrogio, Roberto Piva, Claudia Voena, Michele Pagano, David T. Levy, Frederick W. Alt, Monica Gostissa, Alberto Zamò and Giorgio Palestro. Their work appears in journals such as Blood, Cancer Research, Proceedings of the National Academy of Sciences, Nature Communications and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.